Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Posner

Showing results (151-160 of 247) with videos related to

Pageof 25
Sort By:
The Lancet. Oncology|January 15, 2011
Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trialJochen H Lorch, Olga Goloubeva, Robert I Haddad, et al.
Journal of the National Cancer Institute|November 7, 1990
Oral zidovudine, continuous-infusion fluorouracil, and oral leucovorin calcium: a phase I studyM R Posner, J W Darnowski, P Calabresi, et al.
American Journal of Clinical Oncology|August 4, 2004
Prospective phase II trial of PFL-induction chemotherapy followed by definitive local treatment for advanced squamous cell carcinoma of the head and neck: 10-year follow-upPhillip M Devlin, Julia Kazakin, Sudeshna Adak, et al.
Cancer|December 15, 1992
High-dose intravenous zidovudine with 5-fluorouracil and leucovorin. A phase I trialM R Posner, J W Darnowski, A B Weitberg, et al.
The Annals of Otology, Rhinology, and Laryngology|May 22, 2014
Tolerability, toxicity, and temporal implications of transoral robotic surgery (TORS) on adjuvant radiation therapy in carcinoma of the head and neckTodd J Carpenter, Benjamin Kann, Michael H Buckstein, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Clinical pharmacokinetics of 3-day continuous infusion cisplatin and daily bolus 5-fluorouracilJ F Belliveau, M R Posner, G W Crabtree, et al.
The Laryngoscope|October 29, 2004
Endoscopic management of hypopharyngeal stenosis after organ sparing therapy for head and neck cancerChristopher A Sullivan, Michael T Jaklitsch, Robert Haddad, et al.
Head & Neck|September 25, 2004
Positron emission tomography with 18F-fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancerA David McCollum, Steven C Burrell, Robert I Haddad, et al.
International Journal of Radiation Oncology, Biology, Physics|December 24, 2010
Efficacy and toxicity of chemoradiotherapy using intensity-modulated radiotherapy for unknown primary of head and neckDavid J Sher, Tracy A Balboni, Robert I Haddad, et al.
Archives of Otolaryngology--Head & Neck Surgery|May 17, 2006
Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancerLaura A Goguen, Marshall R Posner, Roy B Tishler, et al.
Pageof 25

Showing results (151-160 of 247) with videos related to

Sort By:
Pageof 25
The Lancet. Oncology|January 15, 2011
Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trialJochen H Lorch, Olga Goloubeva, Robert I Haddad, et al.
Journal of the National Cancer Institute|November 7, 1990
Oral zidovudine, continuous-infusion fluorouracil, and oral leucovorin calcium: a phase I studyM R Posner, J W Darnowski, P Calabresi, et al.
American Journal of Clinical Oncology|August 4, 2004
Prospective phase II trial of PFL-induction chemotherapy followed by definitive local treatment for advanced squamous cell carcinoma of the head and neck: 10-year follow-upPhillip M Devlin, Julia Kazakin, Sudeshna Adak, et al.
Cancer|December 15, 1992
High-dose intravenous zidovudine with 5-fluorouracil and leucovorin. A phase I trialM R Posner, J W Darnowski, A B Weitberg, et al.
The Annals of Otology, Rhinology, and Laryngology|May 22, 2014
Tolerability, toxicity, and temporal implications of transoral robotic surgery (TORS) on adjuvant radiation therapy in carcinoma of the head and neckTodd J Carpenter, Benjamin Kann, Michael H Buckstein, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Clinical pharmacokinetics of 3-day continuous infusion cisplatin and daily bolus 5-fluorouracilJ F Belliveau, M R Posner, G W Crabtree, et al.
The Laryngoscope|October 29, 2004
Endoscopic management of hypopharyngeal stenosis after organ sparing therapy for head and neck cancerChristopher A Sullivan, Michael T Jaklitsch, Robert Haddad, et al.
Head & Neck|September 25, 2004
Positron emission tomography with 18F-fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancerA David McCollum, Steven C Burrell, Robert I Haddad, et al.
International Journal of Radiation Oncology, Biology, Physics|December 24, 2010
Efficacy and toxicity of chemoradiotherapy using intensity-modulated radiotherapy for unknown primary of head and neckDavid J Sher, Tracy A Balboni, Robert I Haddad, et al.
Archives of Otolaryngology--Head & Neck Surgery|May 17, 2006
Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancerLaura A Goguen, Marshall R Posner, Roy B Tishler, et al.
Pageof 25